Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

3.580

-0.140 (-3.76%)

At close: Jul 31, 2026, 4:00 PM EDT

3.590

+0.010 (0.28%)

After-hours: Jul 31, 2026, 7:59 PM EDT

Fulcrum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	48.47	197.53	58.21	25.56	35.1	35.41
Short-Term Investments	270.37	154.77	182.81	210.66	167.82	182.75
Cash & Short-Term Investments	318.84	352.31	241.02	236.22	202.92	218.16
Cash Growth	48.91%	46.17%	2.03%	16.41%	-6.99%	93.21%
Accounts Receivable	-	-	2.1	0.54	0.23	3.64
Other Current Assets	4.01	5.17	6.81	5.44	4.37	4.2
Total Current Assets	322.85	357.48	249.92	242.2	207.52	226
Net Property, Plant & Equipment	-	7.07	9.58	12.39	15.97	7.37
Other Long-Term Assets	1.1	1.74	1.21	3.1	3.2	1.63
Total Assets	323.95	366.28	260.72	257.69	226.69	235
Accounts Payable	3.43	1.59	1.16	2.76	3.64	4.79
Accrued Expenses	4.36	9.05	7.69	8.73	9.55	9.23
Current Portion of Leases	2.52	2.4	2.19	2.19	2.6	-
Unearned Revenue	-	-	-	-	0.93	4.71
Other Current Liabilities	-	-	-	-	-	0.47
Total Current Liabilities	10.3	13.05	11.04	13.68	16.73	19.2
Long-Term Leases	2.76	4.04	6.44	8.63	10.82	-
Other Long-Term Liabilities	0.2	0.2	0.2	0.2	0.2	4.26
Total Long-Term Liabilities	2.96	4.24	6.64	8.83	11.02	4.26
Total Liabilities	13.26	17.28	17.68	22.5	27.74	23.46
Common Stock	0.08	0.07	0.05	0.06	0.05	0.04
Additional Paid-in Capital	950.54	943.04	762.25	744.94	612.03	514.36
Accumulated Other Comprehensive Income	-0.57	0.17	0.13	-0.14	-0.8	-0.4
Retained Earnings	-639.35	-594.28	-519.4	-509.67	-412.34	-302.47
Shareholders' Equity	310.7	349	243.03	235.19	198.94	211.54
Total Liabilities & Equity	323.95	366.28	260.72	257.69	226.69	235
Total Debt	5.28	6.44	8.63	10.82	13.42	0
Net Cash (Debt)	313.56	345.86	232.39	225.4	189.5	218.16
Net Cash Growth	51.82%	48.83%	3.10%	18.95%	-13.14%	93.21%
Net Cash Per Share	4.47	5.46	3.75	3.68	4.21	6.17
Book Value	310.7	349	243.03	235.19	198.94	211.54
Book Value Per Share	4.42	5.51	3.92	3.84	4.42	5.98
Tangible Book Value	310.7	349	243.03	235.19	198.94	211.54
Tangible Book Value Per Share	4.42	5.51	3.92	3.84	4.42	5.98

SEC Filings: 10-K · 10-Q